Status:
UNKNOWN
A Digital Smoking Cessation Intervention for Adults With Substance Use Disorder
Lead Sponsor:
BrightView LLC
Collaborating Sponsors:
Interact for Health
DynamiCare Health
Conditions:
Tobacco Use Disorder
Substance Use Disorders
Eligibility:
All Genders
18+ years
Brief Summary
Adults with substance use disorder (SUD) tend to have started smoking at a younger age and are more likely to be heavy smokers. Due to the many conflicting priorities in this population, smoking cessa...
Detailed Description
In September 2019, the National Institute on Drug Abuse cited research that found smoking rates as high as 85% among patients in treatment for substance use disorder, which is substantially higher tha...
Eligibility Criteria
Inclusion
- Must be enrolled in a BrightView outpatient substance use disorder program
- Must be active smokers, at least moderate in severity
- Must have substance use disorder as their primary diagnosis
- Must speak and read English adequately to understand smartphone commands and responses
- Must have and use an Android or iOS smartphone with acceptable capability
- Must be willing to participate in breath testing and use of the smartphone
Exclusion
- Non-smokers
- Those without a smartphone or access to a smartphone
Key Trial Info
Start Date :
April 2 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 15 2021
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04419922
Start Date
April 2 2020
End Date
January 15 2021
Last Update
June 9 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
BrightView Colerain Addiction Treatment Center
Cincinnati, Ohio, United States, 45239